Navigate to Your Specialty
With over 40 years as the leader in delivering quality HbA1c results to healthcare providers and their patients, Bio-Rad is your go-to source for educational resources and testing solutions for diabetes.
Learn about the current status and future of testing for disorders like thalassemia and sickle cell disease. Our decades of experience delivers relevant resources and solutions.
Diagnosing Diabetes
Missing One Diagnosis Is One Too Many
With a strong predictive value for diabetes complications, HbA1c testing should be done routinely in all people with diabetes at initial assessment and as part of continuing care.
The American Diabetes Association (ADA) recommends using NGSP-certified assays and an A1C goal for adults of ≤6.5% (48 mmol/mol).1
Explore HbA1c Testing Solutions
1. American Diabetes Association Professional Practice Committee (2023). 6. Glycemic Targets: Standards of Medical Care in Diabetes-2023. Diabetes Care 46 (Suppl 1), S97-S110.
Testing for Hemoglobinopathies
Tackling a Global Health Burden
Hemoglobinopathies are the most common severe single-gene disorders worldwide, with over 330,000 affected infants born annually. Although thalassemia and sickle cell disease are among the most common monogenic hemoglobin disorders in the world, disease awareness is still far from acceptable. To learn more, view "Thalassemia and Sickle Cell: Past, Present and Future" webinar, presented by Dr. Michael Angastinioti and Dr. Daniel E. Bauer.
